Coherus BioSciences (CHRS) Reports Q1 Loss Per Share of $1.22
Coherus BioSciences (NASDAQ: CHRS) reported Q1 EPS of ($1.22), versus ($6.03) reported last year.
For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.
Coherus BioSciences (NASDAQ: CHRS) reported Q1 EPS of ($1.22), versus ($6.03) reported last year.
For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.